• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Long QT Syndrome

Long QT Syndrome - 33 Studies Found

COMPLETED : Reducing the Risk of Drug-Induced QT Interval Lengthening in Women
: Long QT Syndrome
: 2025-08-02
: Subjects will receive oral progesterone 400 mg (two x 200 mg capsules) once daily every evening for 7 days
COMPLETED : Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening
: Long QT Syndrome
: 2025-08-02
: Subjects will receive oral progesterone 400 mg (two x 200 mg capsules) once daily every evening for 7 days
COMPLETED : Mutation-specific Therapy for the Long QT Syndrome
: Long QT Syndrome
: 2025-08-02
: Total daily dose: 800 mg of Lumacaftor and 500 mg of Ivacaftor.Duration of treatment: according to the clinical conditions of the patient an
<<< Previous
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.